Form 8-K - Current report:
SEC Accession No. 0001104659-26-080058
Filing Date
2026-07-02
Accepted
2026-07-02 06:20:28
Documents
17
Period of Report
2026-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2619637d1_8k.htm   iXBRL 8-K 31057
2 EXHIBIT 5.1 tm2619637d1_ex5-1.htm EX-5.1 11196
3 EXHIBIT 10.1 tm2619637d1_ex10-1.htm EX-10.1 226215
4 EXHIBIT 10.2 tm2619637d1_ex10-2.htm EX-10.2 84844
5 EXHIBIT 99.1 tm2619637d1_ex99-1.htm EX-99.1 16186
9 GRAPHIC tm2619637d1_ex5-1img001.jpg GRAPHIC 10883
10 GRAPHIC tm2619637d1_ex5-1img002.jpg GRAPHIC 5856
  Complete submission text file 0001104659-26-080058.txt   650638

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA eltx-20260701.xsd EX-101.SCH 3002
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE eltx-20260701_lab.xml EX-101.LAB 34239
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eltx-20260701_pre.xml EX-101.PRE 22350
20 EXTRACTED XBRL INSTANCE DOCUMENT tm2619637d1_8k_htm.xml XML 3208
Mailing Address 451 D STREET, 5TH FLOOR BOSTON MA 02210
Business Address 451 D STREET, 5TH FLOOR BOSTON MA 02210 (857) 209-0050
Elicio Therapeutics, Inc. (Filer) CIK: 0001601485 (see all company filings)

EIN.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39990 | Film No.: 261147658
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)